Image: PetCure Oncology

PetCure Oncology Launches Clinical Trial for the Treatment of Canine Lung Tumors with SRS

boxer-dog-breed

In the world of pet cancer, lung tumors are a particularly nasty foe. But hope is on the horizon.

PetCure Oncology is excited to announce our first clinical trial. It is intended to test a theory that has already been proven in human medicine:

Stereotactic radiosurgery (SRS) could be the answer for many patients suffering from lung cancer. 

SRS has been the standard of care in human oncology for decades, combining radiation therapy with advanced technology to deliver radiation with sub-millimeter precision, fewer side effects, and sometimes even curative intent. More recently, SRS has also become the treatment of choice for humans with primary lung tumors. At the American Society for Radiation Oncology (ASTRO) annual meeting in the fall of 2016, a study of lung cancer patients across the Veterans Health Administration found that radiation delivered stereotactically led to “improved survival” and “40 percent decrease in the risk of death” in humans.

Imaging of Canine Lung Tumor for SRS plan

Above is a 3D reconstruction showing the internal anatomy of a PetCure Oncology patient with a lung tumor. This interactive imaging is used by a radiation oncologist to create an SRS treatment plan.

“SRS has been used to successfully treat lung tumors in humans, in large part because it is noninvasive and highly targeted,” added Dr. Neal Mauldin, PetCure Oncology’s chief medical officer and a triple-board certified radiation oncologist. “Studies have revealed that SRS is well-tolerated by the patient, results in minimal complications or side effects, maintains or improves quality of life, and results in equivalent survival times when compared to surgery for patients with operable tumors.”

For that reason, the clinical trial is intended to prove a simple hypothesis: Dogs with primary lung tumors can also be safely and effectively treated with image-guided SRS.

Visit our clinical trials page for more information, including the terms of the study, a full list of exclusions, and both online and print application forms. Pet parents of trial participants will benefit from heavily subsidized treatment as well as free pre-treatment consults and imaging (CT) and free post-treatment checkups and follow-up imaging.

If you or someone you know has a dog with a diagnosed or suspected lung tumor, we are here to help.

We’re here for you.

Need more information? Reach out to us at any time by calling 773-850-3400 or sending an email to ClinicalTrials@PetCureOncology.com.

Save

Published March 13, 2017 | By PetCure Oncology | Tagged , , , | Return to Blog.


0 Comments


BACK TO TOP
single-job.php